PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers.

Sabari, J K; Leonardi, G C; Shu, C A; Umeton, R; Montecalvo, J; Ni, A; Chen, R; Dienstag, J; Mrad, C; Bergagnini, I; Lai, W V; Offin, M; Arbour, K C; Plodkowski, A J; Halpenny, D F; Paik, P K; Li, B T; Riely, G J; Kris, M G; Rudin, C M; Sholl, L M; Nishino, M; Hellmann, M D; Rekhtman, N; Awad, M M; Drilon, A

Sabari, J K; Leonardi, G C; Shu, C A; Umeton, R; Montecalvo, J; Ni, A; Chen, R; Dienstag, J; Mrad, C; Bergagnini, I; Lai, W V; Offin, M; Arbour, K C; Plodkowski, A J; Halpenny, D F; Paik, P K; Li, B T; Riely, G J; Kris, M G; Rudin, C M; Sholl, L M; Nishino, M; Hellmann, M D; Rekhtman, N; Awad, M M; Drilon, A.

Affiliation

Sabari JK; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Leonardi GC; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
Shu CA; Division of Hematology Oncology, Department of Medicine, Columbia University, New York, USA.
Umeton R; Department of Informatics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
Montecalvo J; Department of Pathology, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, USA.
Ni A; Department of Epidemiology and Biostatistics, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, USA.
Chen R; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Dienstag J; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Mrad C; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Bergagnini I; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Lai WV; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Offin M; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Arbour KC; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Plodkowski AJ; Department of Radiology, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, USA.
Halpenny DF; Department of Radiology, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, USA.
Paik PK; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Li BT; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA; Department of Early Drug Development Service, Division of Solid Tumor Oncology, Department of Medicine, Weill Cornell Medical Col
Riely GJ; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Kris MG; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Rudin CM; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Sholl LM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Nishino M; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; Department of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
Hellmann MD; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA.
Rekhtman N; Department of Informatics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
Awad MM; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
Drilon A; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA; Department of Early Drug Development Service, Division of Solid Tumor Oncology, Department of Medicine, Weill Cornell Medical Col

Ann Oncol ; 29(10): 2085-2091, 2018 10 01.

Article in En | MEDLINE | ID: mdl-30165371

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Exons / Carcinoma, Non-Small-Cell Lung / Proto-Oncogene Proteins c-met / B7-H1 Antigen / Antineoplastic Agents, Immunological / Lung Neoplasms / Mutation Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google